March 31, 2010 13:52 ET

Final dividend 2009 Royal DSM N.V.

HEERLEN, NETHERLANDS--(Marketwire - March 31, 2010) -

The DSM Annual General Meeting of Shareholders on 31 March 2010 passed a resolution to declare a dividend for 2009 of EUR 1.20 per ordinary share of EUR 1.50 par value. An interim dividend of EUR 0.40 per ordinary share having been paid on 28 August 2009, the final dividend for 2009 will amount to EUR 0.80 per ordinary share.

This final dividend of EUR 0.80 will be paid out entirely in cash, after deduction of 15% dividend tax, and will be made payable from 30 April 2010. The ex-dividend date on Euronext Amsterdam will be 6 April 2010.

Holders of registered shares listed in the register of shares kept by ANT will be informed by ANT about the payment to which they are entitled. Holders of shares held in a securities account will receive the final dividend through their bank or broker in whose custody the shares are held on 8 April 2010 at the close of business (record date). The dividend will be made payable to them through the Royal Bank of Scotland N.V. (RBS), which is an authorized agent of the Royal Bank of Scotland plc.

RBS is offering all DSM shareholders the option to participate in the dividend reinvestment plan (DRIP). For more information see the Investors section at

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic prosperity, environmental quality and social equity, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR 8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information:


Press release-pdf:

Contact Information

  • For more information:
    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    fax +31 (0) 45 5740680
    e-mail Email Contact
    Email Contact
    Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 10 4590275